5-90807708-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032119.4(ADGRV1):​c.14943G>C​(p.Gln4981His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000333 in 1,587,746 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 2 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.05

Publications

2 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068824887).
BP6
Variant 5-90807708-G-C is Benign according to our data. Variant chr5-90807708-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00186 (283/152356) while in subpopulation AFR AF = 0.0064 (266/41586). AF 95% confidence interval is 0.00576. There are 0 homozygotes in GnomAd4. There are 120 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032119.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRV1
NM_032119.4
MANE Select
c.14943G>Cp.Gln4981His
missense
Exon 73 of 90NP_115495.3
ADGRV1
NR_003149.2
n.14959G>C
non_coding_transcript_exon
Exon 73 of 90

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRV1
ENST00000405460.9
TSL:1 MANE Select
c.14943G>Cp.Gln4981His
missense
Exon 73 of 90ENSP00000384582.2
ADGRV1
ENST00000638510.1
TSL:1
n.2210G>C
non_coding_transcript_exon
Exon 9 of 26
ADGRV1
ENST00000425867.3
TSL:5
c.3897G>Cp.Gln1299His
missense
Exon 21 of 38ENSP00000392618.3

Frequencies

GnomAD3 genomes
AF:
0.00186
AC:
283
AN:
152238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00642
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000422
AC:
103
AN:
244338
AF XY:
0.000241
show subpopulations
Gnomad AFR exome
AF:
0.00658
Gnomad AMR exome
AF:
0.0000301
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.000171
AC:
245
AN:
1435390
Hom.:
2
Cov.:
30
AF XY:
0.000127
AC XY:
90
AN XY:
711118
show subpopulations
African (AFR)
AF:
0.00646
AC:
212
AN:
32838
American (AMR)
AF:
0.000139
AC:
6
AN:
43290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25446
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39276
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82626
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52824
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5660
European-Non Finnish (NFE)
AF:
0.00000365
AC:
4
AN:
1094474
Other (OTH)
AF:
0.000373
AC:
22
AN:
58956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00186
AC:
283
AN:
152356
Hom.:
0
Cov.:
32
AF XY:
0.00161
AC XY:
120
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00640
AC:
266
AN:
41586
American (AMR)
AF:
0.000980
AC:
15
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000273
Hom.:
0
Bravo
AF:
0.00204
ESP6500AA
AF:
0.00674
AC:
25
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000488
AC:
59

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gln4981His in Exon 73 of GPR98: This variant is not expected to have clinical si gnificance because it has been identified in 0.7% (20/3016) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS).

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 04, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Apr 16, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

ADGRV1-related disorder Benign:1
Jul 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
15
DANN
Benign
0.92
DEOGEN2
Benign
0.090
T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.0076
T
MetaRNN
Benign
0.0069
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.1
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.87
N
REVEL
Benign
0.025
Sift
Benign
0.22
T
Sift4G
Benign
0.41
T
Polyphen
0.0
B
Vest4
0.064
MutPred
0.27
Gain of sheet (P = 0.1208)
MVP
0.38
MPC
0.047
ClinPred
0.012
T
GERP RS
4.0
Varity_R
0.077
gMVP
0.34
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200153555; hg19: chr5-90103525; API